Beijing Strong Biotechnologies Inc banner

Beijing Strong Biotechnologies Inc
SZSE:300406

Watchlist Manager
Beijing Strong Biotechnologies Inc Logo
Beijing Strong Biotechnologies Inc
SZSE:300406
Watchlist
Price: 11.74 CNY -1.18% Market Closed
Market Cap: ¥6.9B

Beijing Strong Biotechnologies Inc
Note Receivable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Beijing Strong Biotechnologies Inc
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Strong Biotechnologies Inc
SZSE:300406
Note Receivable
¥4.2m
CAGR 3-Years
-36%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Note Receivable
¥83.7m
CAGR 3-Years
18%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
RemeGen Co Ltd
SSE:688331
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Beijing Strong Biotechnologies Inc
Glance View

Market Cap
6.9B CNY
Industry
Biotechnology

Beijing Strong Biotechnologies Inc. has carved a niche in the dynamic landscape of medical diagnostics and biotechnology, establishing itself as a prominent player in the industry. Founded in the bustling heart of China, the company has diligently pursued the development and commercialization of in vitro diagnostic reagents and instruments. Their journey began with a vision to enhance the precision and efficiency of diagnostic procedures, quickly progressing towards the production of advanced biochemical diagnostic products. Utilizing cutting-edge technology and rigorous quality control, Beijing Strong Biotechnologies ensures their offerings meet the ever-growing demands of the healthcare sector both domestically and internationally. The company's revenue model is primarily built around the sales of its diagnostic products, which include an extensive range of reagents and testing kits utilized in hospitals and laboratories around the world. As healthcare providers continually seek to improve the accuracy and speed of patient diagnoses, Beijing Strong Biotechnologies stands to benefit from this enduring trend. Their portfolio is diversified, catering not only to a spectrum of routine testing needs but also tapping into specialized segments that command premium pricing due to their complexity and critical application. By innovating and continually refining their product lines, the company ensures a strong market presence and maintains steady growth within the global arena.

Intrinsic Value
15.99 CNY
Undervaluation 27%
Intrinsic Value
Price ¥11.74

See Also

What is Beijing Strong Biotechnologies Inc's Note Receivable?
Note Receivable
4.2m CNY

Based on the financial report for Sep 30, 2025, Beijing Strong Biotechnologies Inc's Note Receivable amounts to 4.2m CNY.

What is Beijing Strong Biotechnologies Inc's Note Receivable growth rate?
Note Receivable CAGR 5Y
-28%

Over the last year, the Note Receivable growth was -66%. The average annual Note Receivable growth rates for Beijing Strong Biotechnologies Inc have been -36% over the past three years , -28% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett